Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Nov
10
2023
From Good Reprint Practices to SIUU Communications: What Firms Need to Know Sheppard, Mullin, Richter & Hampton LLP
Jul
9
2010
EPA Proposes 'Veto' of Section 404 Permit for Mountaintop Removal Coal Mining Project in West Virginia Sheppard, Mullin, Richter & Hampton LLP
Feb
12
2011
California Court Issues Tentative Ruling Enjoining AB 32 Implementation Sheppard, Mullin, Richter & Hampton LLP
Jan
10
2018
Notes on Day 2 of the JP Morgan Healthcare Conference Sheppard, Mullin, Richter & Hampton LLP
Aug
9
2021
California Breaks New Ground With OCal: Answers to Key Questions About “Comparable-to-Organic” Cannabis Sheppard, Mullin, Richter & Hampton LLP
Oct
8
2013
Governor Brown Signs Senate Bill 4 Regulating Hydraulic Fracturing Well Stimulation Treatments Sheppard, Mullin, Richter & Hampton LLP
Feb
11
2019
HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates Sheppard, Mullin, Richter & Hampton LLP
Feb
16
2022
Restructure This! Episode 3: Canada: Cannabis Boom or Bust? [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Mar
1
2022
Treasury Department Recommends Antitrust Reform in Alcohol Markets Sheppard, Mullin, Richter & Hampton LLP
Mar
18
2022
OIG Advisory Opinion Alert: Yet Another Favorable Decision for Medical Device Manufacturers Sheppard, Mullin, Richter & Hampton LLP
Mar
21
2019
E-Cig Company Settles Online Behavioral Advertising Inquiry Sheppard, Mullin, Richter & Hampton LLP
Apr
29
2022
International Cooperation under China’s Proposed Implementing Rules for Human Genetic Resources Management Sheppard, Mullin, Richter & Hampton LLP
Nov
21
2014
Faulty Damages Model Leads to Partial Decertification in California Sheppard, Mullin, Richter & Hampton LLP
Jun
20
2022
Supreme Court Saves Hospitals from $1.6B Cut to 340B Program Sheppard, Mullin, Richter & Hampton LLP
Jun
23
2022
FDA Issues Untitled Letter to Althera Pharmaceuticals for Statements Relating to ROSZET® Sheppard, Mullin, Richter & Hampton LLP
Jul
29
2019
CBO Report Shows Senate’s Bipartisan Bill on Surprise Billing, Drug Prices, Transparency, and More Would Result in Deficit Decrease Sheppard, Mullin, Richter & Hampton LLP
Dec
27
2022
FDA Expands Inspection Guidance to Apply to Device Manufacturers Sheppard, Mullin, Richter & Hampton LLP
Mar
7
2023
DEA Proposes Rule for Post-PHE Telemedicine Sheppard, Mullin, Richter & Hampton LLP
Apr
26
2023
Withdrawal of Drug Approval Highlights Risk of Accelerated Approval Pathway Sheppard, Mullin, Richter & Hampton LLP
Jun
14
2023
New York Landlords May Get Stuck with the Bill for Unlicensed Cannabis Sticker Shops Sheppard, Mullin, Richter & Hampton LLP
Jun
21
2023
The Drug Price Negotiation Program Faces Pushback from Private and Public Industry Participants Sheppard, Mullin, Richter & Hampton LLP
Apr
2
2020
CMS Issues Temporary Waivers in Broad Coronavirus Response Sheppard, Mullin, Richter & Hampton LLP
Apr
23
2020
EEOC Updates Guidance To Permit Employer-Mandated COVID-19 Testing (US) Sheppard, Mullin, Richter & Hampton LLP
May
1
2020
Where’s the Meat? Interim Federal Guidance for Meat Plant Worker Safety Sheppard, Mullin, Richter & Hampton LLP
Feb
5
2024
Cannabis Rescheduling: HHS Findings and Legal Implications Sheppard, Mullin, Richter & Hampton LLP
Sep
18
2020
The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry Sheppard, Mullin, Richter & Hampton LLP
Apr
1
2024
FDCA Preemption: A Powerful Tool for Defending Class Actions Sheppard, Mullin, Richter & Hampton LLP
Jul
14
2010
Elimination of Customs Duties Possible for Over 700 Additional Pharmaceutical Products and Chemical Intermediates Sheppard, Mullin, Richter & Hampton LLP
Jan
10
2018
WARNING: Prop 65 Has Changed – If Your Product Is Sold In California Or You Do Business In California, Pay Attention Sheppard, Mullin, Richter & Hampton LLP
Jan
19
2018
WARNING: There Are New Warning Requirements for Imports Sold in California Sheppard, Mullin, Richter & Hampton LLP
Sep
12
2018
Brady v. Bayer Corp: One A Day Will Not Keep Plaintiffs Away Sheppard, Mullin, Richter & Hampton LLP
Nov
20
2018
Blog Series Part 7: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for 2020 and 2021 Sheppard, Mullin, Richter & Hampton LLP
Jan
11
2022
Day One Notes for the 40th Annual J.P. Morgan Healthcare Conference, 2022 Sheppard, Mullin, Richter & Hampton LLP
Jun
19
2014
Supreme Court Rules Compliance with Food and Drug Administration (FDA) Labeling Guidelines Does Not Bar Lanham Act False Advertising Suits – POM Wonderful v. Coca-Cola Co. Sheppard, Mullin, Richter & Hampton LLP
Dec
27
2014
J.M. Smucker Company Gets Out of a Jam in Food Labelling Case - Caldera v. The J.M. Smucker Co. Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins